Sandip Basu

Sandip Basu is an Indian physician of Nuclear Medicine and the Head, Nuclear Medicine Academic Program at the Radiation Medicine Centre (Bhabha Atomic Research Centre). He is also the Dean-Academic (Health-Sciences), BARC at Homi Bhabha National Institute and is known for his services and research in Nuclear Medicine, particularly on Positron emission tomography diagnostics and Targeted Radionuclide Therapy in Cancer. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Nuclear Medicine in 2012. Provided by Wikipedia
Showing 1 - 20 results of 26 for search 'Sandip Basu', query time: 0.17s Refine Results
  1. 1
    Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (18F-fluorodeoxyglucose and68Ga-DOTATATE) correlates and their treatment implications
    by Sarvesh Loharkar, Sandip Basu
    Published 2021-01-01
    Get full text
    Article
  2. 2
    Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
    by Ashwini Kalshetty, Sandip Basu
    Published 2020-01-01
    Get full text
    Article
  3. 3
    Case work-up and monitoring of systemic radionuclide therapies: A proposed 3-sheet excel format with integrated graph for implementation in a busy treatment set-up
    by Sarvesh Loharkar, Sandip Basu
    Published 2020-01-01
    Get full text
    Article
  4. 4
    Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography (68Ga-DOTATATE and18F-fluorodeoxyglucose) molecular imaging and disease stabilization following177Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy
    by Sonali Jadhav, Sandip Basu
    Published 2019-01-01
    Get full text
    Article
  5. 5
    177Lu-DOTATATE peptide receptor radionuclide therapy in patients with borderline low and discordant renal parameters: Treatment feasibility assessment by sequential estimation of triple parameters and filtration fraction
    by Chinna Naik, Sandip Basu
    Published 2018-01-01
    Get full text
    Article
  6. 6
    Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndrome
    by Chinna Naik, Sandip Basu
    Published 2017-01-01
    Get full text
    Article
  7. 7
    Metabolic bone disease in the context of metastatic neuroendocrine tumor: differentiation from skeletal metastasis, the molecular PET-CT imaging features, and exploring the possible etiopathologies including parathyroid adenoma (MEN1) and paraneoplastic humoral hypercalcemia of malignancy due to PTHrp hypersecretion
    by Rohit Ranade, Sandip Basu
    Published 2017-01-01
    Get full text
    Article
  8. 8
    Midline or near-midline radioiodine uptake in the oropharyngeal region in patients of differentiated thyroid carcinoma: Differential diagnosis between lingual thyroid and retropharyngeal nodal metastasis, the subtle clues in the scan and their implications for patient management
    by Pradeep Thapa, S Joshi, Sandip Basu
    Published 2015-01-01
    Get full text
    Article
  9. 9
    Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and 131I
    by Rahul V Parghane, Sandip Basu
    Published 2021-01-01
    Get full text
    Article
  10. 10
    Comparative evaluation of iodine-131 metaiodobenzylguanidine and 18-fluorodeoxyglucose positron emission tomography in assessing neural crest tumors: Will they play a complementary role?
    by Soumyakanti Kundu, Purushottam Kand, Sandip Basu
    Published 2017-01-01
    Get full text
    Article
  11. 11
    Splinting of penis following microvascular reconstruction- A simple inexpensive method
    by Abhishek Sharma, Ashutosh Misra, Sandip Basu
    Published 2009-07-01
    Get full text
    Article
  12. 12
    “Tumour sink effect” on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice
    by Sandip Basu, Rohit Ranade, Amit Abhyankar
    Published 2020-01-01
    Get full text
    Article
  13. 13
    Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis
    by Aadil Adnan, Nikita Sampathirao, Sandip Basu
    Published 2019-01-01
    Get full text
    Article
  14. 14
    Multimodality molecular imaging (FDG-PET/CT, US elastography, and DWI-MRI) as complimentary adjunct for enhancing diagnostic confidence in reported intermediate risk category thyroid nodules on bethesda thyroid cytopathology reporting system
    by Sandip Basu, Abhishek Mahajan, Supreeta Arya
    Published 2016-01-01
    Get full text
    Article
  15. 15
    177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites
    by Pradeep Thapa, Rahul Parghane, Sandip Basu
    Published 2017-01-01
    Get full text
    Article
  16. 16
    Metastatic neuroendocrine tumor with extensive bone marrow involvement at diagnosis: Evaluation of response and hematological toxicity profile of PRRT with 177Lu-DOTATATE
    by Sandip Basu, Rohit Ranade, Pradeep Thapa
    Published 2016-01-01
    Get full text
    Article
  17. 17
    18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation
    by Pradeep Thapa, Ashwini Kalshetty, Sandip Basu
    Published 2018-01-01
    Get full text
    Article
  18. 18
    Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care
    by Vandana K Dhingra, Abhishek Mahajan, Sandip Basu
    Published 2015-10-01
    Get full text
    Article
  19. 19
    Evaluating cardiac hypoxia in hibernating myocardium: Comparison of 99mTc-MIBI/18F-fluorodeoxyglucose and 18F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
    by Rajlaxmi Jagtap, Ramesh V Asopa, Sandip Basu
    Published 2019-01-01
    Get full text
    Article
  20. 20
    Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
    by Rahul V Parghane, Sanjay Talole, Sandip Basu
    Published 2019-01-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search